Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 4 Regulatory News (MIG4)

Share Price Information for Mobeus I&g 4 (MIG4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (4.511%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 68.00
MIG4 Live PriceLast checked at -
Mobeus Income & Growth 4 VCT is an Investment Trust

To provide investors with a regular income stream and to generate capital growth by investing primarily in a diverse portfolio of UK unquoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

20 May 2024 07:00

RNS Number : 9999O
Mobeus Income & Growth 4 VCT PLC
20 May 2024
 

MOBEUS INCOME & GROWTH 4 VCT PLC 

("the Company")

LEI: 213800IFNJ65R8AQW943

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2024

 

Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 31 March 2024. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 March 2024

(unaudited)

At 31 December 2023

(audited)

Net assets attributable to shareholders

£80.19 million

£81.24 million

Shares in issue

111,656,815

111,141,509

Net asset value (NAV) per share

71.81 pence

73.09 pence

Cumulative dividends paid

166.20 pence

164.20 pence

Cumulative Total return (net asset value basis) per share since inception

238.01 pence

237.29 pence

 

The NAV per share, after adding back the dividend of 2.00 pence per share paid on 22 March 2024 has increased by 0.72 pence per share (an increase of 1.0% from the opening NAV per share).

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New Investment during the period

On 19 March 2024, the Company completed a new investment of £0.60 million into SciLeads Limited, a data-intelligence platform within the life science sector.  

 

Further Investments during the period

On 10 January 2024, a follow on investment of £0.47 million was made into MyTutorWeb Limited (trading as MyTutor), a digital marketplace for online tutoring.

 

On 25 March 2024, a follow on loan investment of £0.06 million was made into Orri Limited, specialists in eating disorder support.

 

 

Realisations during the period

 

On 15 February 2024, proceeds of £2.91 million were received in respect of the sale of Master Removers Group 2019 Limited (trading as Anthony Ward Thomas, Bishopsgate and Aussie Man & Van). These proceeds contributed to a multiple on cost of 3.3x over the life of this investment. Further proceeds may be receivable in due course.

 

DIVIDEND PAID DURING THE PERIOD

An interim dividend of 2.00 pence per share in respect of the year ending 31 December 2024 was declared on 6 February 2024 and was paid on 22 March 2024 to all Shareholders whose names were on the register on 16 February 2024.

 

DIVIDEND INVESTMENT SCHEME ("DIS")

On 22 March 2024, 515,306 new Ordinary shares were allotted through the DIS at a price of 71.06 pence per share.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

Further Investments after the period end

On 3 May 2024, the Company completed a follow on investment of £1.39 million into Data Discovery Solutions Limited (trading as ActiveNav), a provider of data discovery solutions for compliance and information governance.

 

SHARE BUYBACK AFTER THE PERIOD END.

On 25 April 2024, the Company purchased 1,106,750 of its own ordinary shares at a price of 67.54 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

 

 

Please note that all of the above information is unaudited.

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDZVLFFZELLBBF
Date   Source Headline
28th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20245:37 pmRNSResult of Annual General Meeting
20th May 20247:00 amRNSInterim Management Statement
1st May 20247:00 amRNSTotal Voting Rights and Capital
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
22nd Mar 202410:02 amRNSDirector/PDMR Shareholding
22nd Mar 202410:00 amRNSIssue of Equity and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
6th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:44 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20232:00 pmRNSInterim Management Statement - replacement
15th Nov 20233:00 pmRNSInterim Management Statement
8th Nov 202310:35 amRNSDirector/PDMR Shareholding
8th Nov 202310:30 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
18th Oct 202310:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSStatement re Change of Registrar
5th Oct 20237:00 amRNSDividend Declaration
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSDirector Declaration
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20232:24 pmRNSDirector/PDMR Shareholding
26th May 202312:57 pmRNSIssue of Equity and Total Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20231:00 pmRNSDividend Declaration
6th Apr 20237:00 amRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20235:28 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:08 amRNSIssue of Supplementary Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.